Compare CTNM & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTNM | NRGV |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.0M | 577.7M |
| IPO Year | 2024 | 2021 |
| Metric | CTNM | NRGV |
|---|---|---|
| Price | $13.06 | $3.30 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.00 | $2.00 |
| AVG Volume (30 Days) | 331.7K | ★ 3.8M |
| Earning Date | 03-05-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.46 | ★ 28.57 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $203,671,000.00 |
| Revenue This Year | N/A | $23.55 |
| Revenue Next Year | N/A | $28.25 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 340.86 |
| 52 Week Low | $3.35 | $0.60 |
| 52 Week High | $16.33 | $6.35 |
| Indicator | CTNM | NRGV |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 44.99 |
| Support Level | $10.17 | $2.95 |
| Resistance Level | $13.18 | $3.54 |
| Average True Range (ATR) | 1.07 | 0.32 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 42.15 | 19.66 |
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.